European Commission inquires Sanofi-Aventis

By Alexandra Steblinina. Sanofi-Aventis, French drug-maker, was visited by the the European Commission members.

Photo: European Commission inquires Sanofi-Aventis

European Commission inquires Sanofi-Aventis

The company’s spokesman said that the visit was connected with an inquiry in the pharmaceutical sector.

No more comments were given.

Sanofi-Aventis, headquartered in Paris , France , is one of the five largest pharmaceutical companies in the world, along with Pfizer, Bristol-Myers Squibb, Novartis, and GlaxoSmithKline. Sanofi-Aventis engages in the research, development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but they also develop over-the-counter medication. Sanofi-Aventis cover 7 major therapeutic areas: cardiovascular, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines (with its subsidiary Sanofi Pasteur).